Attenuation of ovarian response by low-dose ketoconazole during superovulation in patients with polycystic ovary syndrome

Fertility and Sterility

Volumn 72, Issue 1, 1999, Pages 26-31

  Eldar Geva, Talia ^a   Margalioth, Ehud J ^a   Orly, Joseph ^a   Diamant, Yoram Z ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Female; Ketoconazole; Ovulation induction; Polycystic ovary syndrome

Indexed keywords

ESTRADIOL; KETOCONAZOLE; PROGESTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; MENSTRUAL CYCLE; OVARY FOLLICLE DEVELOPMENT; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; STEROIDOGENESIS; SUPEROVULATION;

ADOLESCENT; ADULT; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FEMALE; HUMANS; KETOCONAZOLE; MENOTROPINS; MENSTRUAL CYCLE; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PROGESTERONE; PROSPECTIVE STUDIES; SUPEROVULATION;

EID: 0033168647     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(99)00188-0     Document Type: Article

References (20)

1. Ron-El R. Complications of ovulation induction. Baillieres Clin Obstet Gynecol. 7:1993;435-453.
2. Buvat J., Buvat Herbaut M., Marcolin G., Dehaene J.L., Verbecq P., Renouard O. Purified follicle stimulating hormone in polycystic ovary syndrome slow administration is safer and more effective . Fertil Steril. 52:1989;553-559.
3. Polson D.W., Mason H.D., Saldahna M.B., Franks S. Ovulation of a single dominant follicle during treatment with low-dose pulsatile follicle stimulating hormone in women with polycystic ovary syndrome. Clin Endocrinol. 26:1987;205-212.
4. Gal M., Orly J., Barr I., Algur N., Boldes R., Diamant Y.Z. Low dose ketoconazole attenuates serum androgen levels in patients with polycystic ovary syndrome and inhibits ovarian steroidogenesis in vitro. Fertil Steril. 61:1994;823-832.
5. World Health Organization . WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. 3rd ed. 1992;43-44 The Press Syndicate of the University of Cambridge, Cambridge.
6. Ferriman D., Gallwey J.D. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 21:1961;1440-1447.
7. Gilman G.A., Goodman L.S., Rall T.W., Murad F., The pharmacological basis of therapeutics. 7th ed. 1985;1226-1227 Collier Macmillan, New York.
8. Lunenfeld B., Insler V., Rabau E. Induction de l'ovulation par les gonadotrophines. Oricard R., Ferrin J., L'ovulation. 1969;27 Masson, Paris.
9. Sonino N. The use of ketoconazole as an inhibitor of steroid production. N Engl J Med. 317:1987;812-818.
10. Pepper G., Brenner S.H., Gabrilove J.L. Ketoconazole use in the treatment of ovarian hyperandrogenism. Fertil Steril. 54:1990;438-444.
11. Isik A.Z., Gokmen O., Zeyneloglu H.B., Senoz S., Zorlu C.G. Low dose ketoconazole is an effective and a relatively safe alternative in the treatment of hirsutism. Aust N Z J Obstet Gynaecol. 36:1996;487-489.
12. Zelinski-Wooten M.B., Hess D.L., Wolf D.P., Stouffer R.L. Steroid reduction during ovarian stimulation impairs oocyte fertilization, but not folliculogenesis, in rhesus monkeys. Fertil Steril. 61:1994;1147-1155.
13. Moudgal N.R., Shetty G., Selvaraj N., Bhatnagar A.S. Use of a specific inhibitor for determining whether there is a role for estrogen in follicle/oocyte maturation, ovulation and preimplantation embryo development. J Reprod Fertil Suppl. 50:1996;69-81.
14. Zelinski-Wooten M.B., Hess D.L., Baughman W.L., Molksness T.A., Wolf D.P., Stouffer R.L. Administration of an aromatase inhibitor during the late follicular phase of gonadotropin-treated cycles in rhesus monkeys effects on follicle development, oocyte maturation, and subsequent luteal function . J Clin Endocrinol Metab. 76:1993;988-995.
15. Decherney A.H., Laufer N. The monitoring of ovulation induction using ultrasound and estrogen. Clin Obstet Gynecol. 27:1984;993-1002.
16. Sallam H.N., Marinho A.O., Collins W.P., Rodeck C.H., Campbell S. Monitoring gonadotrophin therapy by real-time ultrasonic scanning of ovarian follicles. Br J Obstet Gynaecol. 89:1982;155-159.
17. 2 assay. Fertil Steril. 42:1984;882-889.
18. Blankstein J., Shalev J., Saadon T., Kukia E.E., Rabinovici J., Pariente C., et al. Ovarian hyperstimulation syndrome prediction by number and size of preovulatory ovarian follicles . Fertil Steril. 47:1987;597-602.
19. Wang C.F., Gemzell C. The use of gonadotropin for the induction of ovulation in women with polycystic ovarian disease. Fertil Steril. 33:1980;479-486.
20. Homburg R. Low dose therapy with FSH endocrine aspects and clinical results . Filicori M., Flamigni C., Proceedings of the 2nd World Conference on Ovulation Induction in Bologna. 1997;61-65 Parthenon Publishing Group, Italy. New York/London.